These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18854656)

  • 1. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L; Kubicka S
    Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapies in hepatocellular carcinoma.
    Wörns MA; Weinmann A; Schuchmann M; Galle PR
    Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy of hepatocellular cancer.
    Wysocki PJ
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factors as therapeutic targets in HCC.
    Furuse J
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):8-15. PubMed ID: 18434184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M
    Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma].
    Kondo S; Ueno H; Morizane C; Okusaka T
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX
    Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
    Chaparro M; González Moreno L; Trapero-Marugán M; Medina J; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1269-77. PubMed ID: 18808443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H
    Biochem Pharmacol; 2010 Sep; 80(5):550-60. PubMed ID: 20371362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy of hepatocellular carcinoma: are we making progress?
    Roxburgh P; Evans TR
    Adv Ther; 2008 Nov; 25(11):1089-104. PubMed ID: 18972075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Kudo M
    Dig Dis; 2011; 29(3):289-302. PubMed ID: 21829020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future treatment option for hepatocellular carcinoma: a focus on brivanib.
    Kudo M
    Dig Dis; 2011; 29(3):316-20. PubMed ID: 21829023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targeting for treatment of advanced hepatocellular carcinoma.
    Song IH
    Korean J Hepatol; 2009 Sep; 15(3):299-308. PubMed ID: 19783879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
    Finn RS
    Clin Cancer Res; 2010 Jan; 16(2):390-7. PubMed ID: 20068087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L; Santoro A
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):739-45. PubMed ID: 19496710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for hepatocellular carcinoma.
    Thomas MB
    Cancer J; 2008; 14(2):123-7. PubMed ID: 18391618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.